Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Exercise 4Cholecalciferol 4Nutrition Assessment 3Gonadotropin-Releasing Hormone 3Blood Pressure 3Atorvastatin 3palbociclib 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2acalabrutinib 2Vitamin E 2Social Determinants of Health 2Rosuvastatin Calcium 2Metformin 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Electrocardiography 2Educational Status 2Echocardiography 2Diet, Mediterranean 2Blood Specimen Collection 2Aspirin 2Antineoplastic Agents 2Absorptiometry, Photon 2zanubrutinib 1xinmailong 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiovascular Diseases × Heart Function Tests × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡